Trials / Completed
CompletedNCT01770795
A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Gachon University Gil Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety Genexol-PM(CrEL-free polymeric micelle formulated paclitaxel)and gemcitabine in untreated metastatic NSCLC patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Genexol-PM/Gemcitabine |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-10-01
- First posted
- 2013-01-18
- Last updated
- 2013-01-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01770795. Inclusion in this directory is not an endorsement.